Myopia
Conditions
Keywords
photobiomodulation,macular microcirculation,,myopia
Brief summary
This project is a single-center, prospective, self-controlled clinical study. It intends to select patients with simple medium and low degree myopia as subjects, and apply 650nm low-energy red light irradiation to the retina to observe its effect on macular microcirculation.
Detailed description
A total of 120 subjects are planned to be recruited and divided into 4 groups according to age and intervention, including 30 in the juvenile intervention group, 30 in the juvenile control group, 30 in the adult intervention group and 30 in the adult control group. Two intervention groups received 650nm low-energy red light irradiation treatment with a 650nm low-energy light emitter, twice a day for 3 minutes each time, The subjects were treated and followed up for 3 months. The control group was not treated and followed up for 3 months too. All subjects were followed up before treatment, at the end of the 1st month and at the end of 3rd month. Angio-oct was used as the main examination to observe and record the vascular density and blood perfusion in macular area. Axial length, diopter and OCT were used as secondary observation indexes. At the end of the experiment, the data of the intervention group and the control group were compared
Interventions
RADIATIONphotobiomodulation
650nm low energy red light eye irradiation
Sponsors
Central South University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
7 Years to 45 Years
Healthy volunteers
No
Inclusion criteria
1. Age from 7 to 17 years old or from 18 to 45 years old; 2. Meet the diagnostic criteria for patients with simple low or moderate myopia, with diopter \< -6.0d and eye axis \< 26.0mm; 3. Transparent refractive stroma, no other eye diseases except nearsightedness; 4. Agree to participate in the clinical study and sign the informed consent.
Exclusion criteria
1. Other ocular lesions, such as uveitis, retinal/choroidal vascular lesions, congenital ocular lesions, glaucoma, high myopia (ocular axis \> 26cm), degenerative retinal disease, optic neuropathy, etc.; 2. Another eye with low vision 3. Corneal edema/epithelial detachment, corneal opacity; 4. Redness, pain, dry eye, photophobia, difficulty in opening eyes; 5. Had a history of eye surgery in recent 3 months; 6. Severe impairment of liver and kidney function and/or serious systemic diseases (such as cardiovascular, respiratory, digestive, nervous, endocrine, genitourinary, etc.); 7. Women who are already pregnant, preparing for pregnancy during the study period and lactating; 8. A history of substance abuse or alcohol abuse; 9. Receiving prevention and control treatment for myopia other than glasses within the first 30 days; 10. Any situation in which the study physician believes that the patient's condition will interfere with the clinical study (e.g., the patient is prone to nervous tension, uncontrollable emotions, depression, etc.)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| retinal vascular density | 12 weeks | The vascular density of the inner retinal layer in the macular area within 3×3mm was measured by angio-OCT |
| retinal vascular perfusion | 12 weeks | The perfusion of the inner retinal layer in the macular area within 3×3mm was measured by angio-OCT |
| Choroid thickness | 12 weeks | Distance from Bruch membrane to The inner surface of the sclera |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Axial length | 12 weeks | Distance from corneal apex to macular fovea |
| diopter | 12 weeks | Myopic degree |
Countries
China
Outcome results
None listed